Acrivon Therapeutics, Inc.'s total assets for Q3 2024 were $214.68M, a decrease of -6.90% from the previous quarter. ACRV total liabilities were $17.79M for the fiscal quarter, a 22.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.